Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY2 | P41231 | 15/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | POLA1 | P09884 | 1/20 | 0.33 |
| ▸ | POLD1 | P28340 | 1/20 | 0.33 |
| ▸ | P2RY4 | P51582 | 7/20 | 0.32 |
| ▸ | GPR17 | Q13304 | 1/20 | 0.31 |
| ▸ | P2RX1 | P51575 | 2/20 | 0.31 |
| ▸ | P2RX3 | P56373 | 2/20 | 0.31 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.31 |
| ▸ | P2RY1 | P47900 | 1/20 | 0.31 |
| ▸ | P2RY6 | Q15077 | 1/20 | 0.31 |
| ▸ | P2RY11 | Q96G91 | 1/20 | 0.31 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.31 |
| ▸ | P2RX2 | Q9UBL9 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18602997 | 1.00 | P2RY2 (0.33) | P2RY2POLBPOLA1POLD1P2RY4 | |
| SCHEMBL272164 | 0.94 | POLB (0.34) | P2RY2POLBPOLA1POLD1P2RY4 | |
| SCHEMBL272582 | 0.85 | P2RY2 (0.36) | P2RY2POLBPOLA1POLD1P2RY4 | |
| SCHEMBL271948 | 0.84 | P2RY2 (0.35) | P2RY2POLBPOLA1POLD1P2RY4 | |
| SCHEMBL21555520 | 0.80 | P2RY2 (0.37) | P2RY2POLBPOLA1POLD1P2RY4 | |
| SCHEMBL22002630 | 0.80 | P2RY2 (0.37) | P2RY2POLBPOLA1POLD1P2RY4 | |
| SCHEMBL21555519 | 0.80 | P2RY2 (0.37) | P2RY2POLBPOLA1POLD1P2RY4 | |
| SCHEMBL25141885 | 0.79 | P2RY2 (0.37) | P2RY2POLBPOLA1POLD1P2RY4 | |
| SCHEMBL271833 | 0.78 | P2RY2 (0.37) | P2RY2POLBPOLA1POLD1P2RY4 | |
| SCHEMBL271945 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8133669-B2 | Chemically modified nucleoside 5′-triphosphates for thermally initiated amplification of nucleic acid | TRILINK BIOTECHNOLOGIES (US) | 2012-03-13 | — | — | US | disclosed |
| US-8133669-B2 | Chemically modified nucleoside 5′-triphosphates for thermally initiated amplification of nucleic acid | TRILINK BIOTECHNOLOGIES (US) | 2012-03-13 | — | — | US | disclosed |
| US-20100003724-A1 | CHEMICALLY MODIFIED NUCLEOSIDE 5'-TRIPHOSPHATES FOR THERMALLY INITIATED AMPLIFICATION OF NUCLEIC ACID | TriLink Bio Technologies | 2010-01-07 | — | — | US | disclosed |
| US-20100003724-A1 | CHEMICALLY MODIFIED NUCLEOSIDE 5'-TRIPHOSPHATES FOR THERMALLY INITIATED AMPLIFICATION OF NUCLEIC ACID | TriLink Bio Technologies | 2010-01-07 | — | — | US | disclosed |